Article Sidebar

PDF
Date Published: 30/03/2023
Abstract Views: 238
Views PDF: 131
DOI: https://doi.org/10.51298/vmj.v524i2.4874
Issue
Vol. 524 No. 2 (2023)
Section
Các bài báo
How to Cite
Nguyễn, H. P. ., Phạm , T. T. T. ., Nguyễn, K. D. ., Trần , T. H. Y. ., & Nguyễn, T. T. H. (2023). OBSERVATION OF COPENHAGEN INDEX ON PATIENTS WITH OVARY TUMORS AT THE NATIONAL HOSPITAL OF OBSTETRICS AND GYNECOLOGY. Vietnam Medical Journal, 524(2). https://doi.org/10.51298/vmj.v524i2.4874

OBSERVATION OF COPENHAGEN INDEX ON PATIENTS WITH OVARY TUMORS AT THE NATIONAL HOSPITAL OF OBSTETRICS AND GYNECOLOGY

Hải Phương Nguyễn1,, Thị Thanh Thủy Phạm 1, Khánh Dương Nguyễn1, Thị Hải Yến Trần 1, Thị Thu Hà Nguyễn1
1 National hospital of obstetrics and gynecology

Main Article Content

Abstract

Objectives: To observate the Copenhagen Index and compare it with the ROMA in patients with ovarian tumors at the National Hospital of Obstetrics and Gynecology. Study method: Retrospective study of 337 patients with ovary tumors treated at the National Hospital of Obstetrics and Gynecology from January 2020 to September 2022. Results: In the ovarian carcinoma patient group, the sensitivity and specificity of cancer diagnosis of the Copenhagen Index was 74.19% and 95.7% and that of the ROMA index was 77.42% and 91.1%. Conclusion: The results of the study showed that the high Copenhagen index was statistically significant for the group of ovarian cancer patients. The Copenhagen index has less sensitivity but higher specificity than the ROMA index. However, more research is needed to find cut-offs that better predict ovarian cancer.

Article Details

Keywords

Copenhagen, CPH-I, HE4, CA125, ROMA, ovarian tumors, ovarian cancer

References

1. Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health. 2019 Apr 30;11:287-299. doi: 10.2147/IJWH.S197604. PMID: 31118829; PMCID: PMC6500433
2. Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018 Jul;68(4):284-296
3. Doubeni CA, Doubeni AR, Myers AE. Diagnosis and Management of Ovarian Cancer. Am Fam Physician. 2016; 93(11): 937-944
4. Karlsen MA, Høgdall EV, Christensen IJ, Borgfeldt C, Kalapotharakos G, Zdrazilova-Dubska L, Chovanec J, Lok CA, Stiekema A, Mutz-Dehbalaie I, Rosenthal AN, Moore EK, Schodin BA, Sumpaico WW, Sundfeldt K, Kristjansdottir B, Zapardiel I, Høgdall CK. A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass. Gynecol Oncol. 2015 Sep;138(3):640-6. doi: 10.1016/j.ygyno.2015.06.021. Epub 2015 Jun 16. PMID: 26086566.
5. Tran DT, Vo VK, Le MT, Chuang L, Nguyen VQH. Copenhagen Index versus ROMA in preoperative ovarian malignancy risk stratification: Result from the first Vietnamese prospective cohort study. Gynecol Oncol. 2021 Jul;162(1):113-119. doi: 10.1016/j.ygyno.2021.05.001. Epub 2021 May 14. PMID: 33994145.
6. Minar L, Felsinger M, Cermakova Z, Zlamal F, Bienertova-Vasku J. Comparison of the Copenhagen Index versus ROMA for the preoperative assessment of women with ovarian tumors. Int J Gynaecol Obstet. 2018 Feb;140(2):241-246. doi: 10.1002/ijgo.12371. Epub 2017 Nov 22. PMID: 29086914.
7. Yoshida A, Derchain SF, Pitta DR, Andrade LA, Sarian LO. Comparing the Copenhagen Index (CPH-I) and Risk of Ovarian Malignancy Algorithm (ROMA): Two equivalent ways to differentiate malignant from benign ovarian tumors before surgery? Gynecol Oncol. 2016 Mar;140(3):481-5.
8. Liberto JM, Chen SY, Shih IM, Wang TH, Wang TL, Pisanic TR 2nd. Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review. Cancers (Basel). 2022 Jun 11;14(12):2885. doi: 10.3390/cancers14122885. PMID: 35740550; PMCID: PMC9221480.